TY - JOUR
T1 - Erectile dysfunction in type 2 diabetic men
T2 - Relationship to exercise fitness and cardiovascular risk factors in the look ahead trial
AU - Rosen, Raymond C.
AU - Wing, Rena R.
AU - Schneider, Stephen
AU - Wadden, Thomas A.
AU - Foster, Gary D.
AU - West, Delia Smith
AU - Kitabchi, Abbas E.
AU - Brancati, Frederick L.
AU - Maschak-Carey, Barbara J.
AU - Bahnson, Judy L.
AU - Lewis, Cora E.
AU - Gendrano, Isaias N.
N1 - Funding Information:
This Look AHEAD trial is supported by the Department of Health and Human Services through the following cooperative agreements from the National Institutes of Health: DK57136, DK57149, DK56990, DK57177, DK57171, DK57151, DK57182, DK57131, DK57002, DK57078, DK57154, DK57178, DK57219, DK57008, DK57135, and DK56992.
Funding Information:
Additional funding support for the sexual dysfunction ancillary study was provided by DK060438 and by an unrestricted grant from Pfizer, Inc.
PY - 2009
Y1 - 2009
N2 - Introduction. Determinants of erectile dysfunction in diabetic men have not been adequately investigated as potential mediators of change. Aim. To determine the prevalence and correlates of erectile dysfunction (ED) in overweight men with type 2 diabetes in the multicenter, Look AHEAD trial (Action for Health in Diabetes). Main Outcome Measures. International Index of Erectile Function (IIEF), self-reported use of phosphodiesterase type 5 inhibitors, laboratory measures of adiposity, cardiometabolic parameters, and exercise fitness. Methods. Male participants aged 45-75 in the Look AHEAD trial in a committed relationship were recruited for an ongoing study of sexual function and diabetes. Eligible participants completed the IIEF questionnaire and provided updated information on use of medical treatments for sexual dysfunction. Baseline sexual function results for participants in the male ancillary study are reported here; intervention data and results for female participants are presented elsewhere. Results. A total of 373 eligible male participants completed all sexual function questionnaires, of whom 263 (68.7%) were sexually active at the time of the study. Almost half (49.8%) of the men reported mild or moderate degrees of ED, and 24.8% had complete ED. Among sexually active participants, 42.6% had sought medical help for their problem, and 39.7% reported use of ED medications. ED was significantly associated with age (odds ratio [OR] = 1.05; confidence interval [CI]: 1.01-1.10) baseline HbA 1c (OR = 1.31; CI: 1.05-1.63), hypertension history (OR=2.41; CI: 1.34-4.36), and metabolic syndrome (OR = 3.05, CI: 1.31-7.11). Of note, cardiorespiratory fitness was found to be protective of ED in a multivariable analysis (OR=0.61; P < 0.001). Conclusions. ED is prevalent in this sample of obese, type 2 diabetic men in the Look AHEAD study. Cardiovascular risk factors were highly associated with ED in this population, and cardiorespiratory fitness was protective in this analysis.
AB - Introduction. Determinants of erectile dysfunction in diabetic men have not been adequately investigated as potential mediators of change. Aim. To determine the prevalence and correlates of erectile dysfunction (ED) in overweight men with type 2 diabetes in the multicenter, Look AHEAD trial (Action for Health in Diabetes). Main Outcome Measures. International Index of Erectile Function (IIEF), self-reported use of phosphodiesterase type 5 inhibitors, laboratory measures of adiposity, cardiometabolic parameters, and exercise fitness. Methods. Male participants aged 45-75 in the Look AHEAD trial in a committed relationship were recruited for an ongoing study of sexual function and diabetes. Eligible participants completed the IIEF questionnaire and provided updated information on use of medical treatments for sexual dysfunction. Baseline sexual function results for participants in the male ancillary study are reported here; intervention data and results for female participants are presented elsewhere. Results. A total of 373 eligible male participants completed all sexual function questionnaires, of whom 263 (68.7%) were sexually active at the time of the study. Almost half (49.8%) of the men reported mild or moderate degrees of ED, and 24.8% had complete ED. Among sexually active participants, 42.6% had sought medical help for their problem, and 39.7% reported use of ED medications. ED was significantly associated with age (odds ratio [OR] = 1.05; confidence interval [CI]: 1.01-1.10) baseline HbA 1c (OR = 1.31; CI: 1.05-1.63), hypertension history (OR=2.41; CI: 1.34-4.36), and metabolic syndrome (OR = 3.05, CI: 1.31-7.11). Of note, cardiorespiratory fitness was found to be protective of ED in a multivariable analysis (OR=0.61; P < 0.001). Conclusions. ED is prevalent in this sample of obese, type 2 diabetic men in the Look AHEAD study. Cardiovascular risk factors were highly associated with ED in this population, and cardiorespiratory fitness was protective in this analysis.
KW - Erectile dysfunction
KW - Phosphodiesterase type 5 inhibitors
KW - Physical activity
KW - Type 2 diabetes
UR - http://www.scopus.com/inward/record.url?scp=65149087305&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=65149087305&partnerID=8YFLogxK
U2 - 10.1111/j.1743-6109.2008.01209.x
DO - 10.1111/j.1743-6109.2008.01209.x
M3 - Article
C2 - 19192106
AN - SCOPUS:65149087305
SN - 1743-6095
VL - 6
SP - 1414
EP - 1422
JO - Journal of Sexual Medicine
JF - Journal of Sexual Medicine
IS - 5
ER -